VLDLR and renal cell carcinoma: This reprogramming leads to the accumulation of cholesterol and lipid droplets, primarily through the increased use of the Very-Low-Density Lipoprotein Receptor (VLDL-R) and Scavenger Receptor Class B Member 1 (SR-B1), which support the rapid proliferation of RCC [19,20].